MRK posts encouraging Q4 results. However, the decision to temporarily halt shipments of Gardasil vaccines to China has ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

To read more about the latest highlights related to the PDC market, get a snapshot of the key highlights entailed in the ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

A trusted partner to 19 of the top 20 pharmaceutical companies, Medidata continues to break ground with new categories of critical patient-centric experiences, seamlessly integrating AI into its suite ...

We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effectiveness and lower systemic toxicity than conventional ...

Ugandan doctors attend the contacts of a patient who had tested positive, during the launch of the vaccination for the Sudan strain of Ebola virus, with a trial vaccine at the Mulago Guest House ...